首页 > 市场调查报告书 > 医疗设备

生技设备基因治疗学和RNAi

市场调查报告书

商品编码

1532617

微阵列扫描仪市场，按产品类型（萤光、电荷耦合元件、比色微阵列扫描仪）、应用（基因表现、蛋白质微阵列、药物发现、基因分型和SNP 分析）、最终用途- 全球预测（ 2024 年- 2032 年）

Microarray Scanners Market, By Product Type (Fluorescence, Charge-coupled Devices, Colorimetric Microarray Scanners), Application (Gene Expression, Protein Microarray, Drug Discovery, Genotyping & SNP Analysis), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年05月28日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于微阵列技术在基因组研究、个人化医疗和诊断领域不断扩大的应用，2024 年至 2032 年间，微阵列扫描器市场规模将达到 8.2% 的复合年增长率。微阵列扫描仪对于分析各个研究领域的基因表现、遗传变异和生物标记至关重要，包括癌症研究、药物发现和遗传性疾病研究。

随着研究人员和临床医生寻求更详细的遗传资料见解以定制治疗方法和开发新的治疗方法，对能够提供准确和全面结果的先进微阵列扫描仪的需求正在增加。例如，2023 年 8 月，Thermo Fisher Scientific 推出了一款新的染色体微阵列，用于提高细胞遗传学研究实验室的生产力、功效和获利能力。

更高解析度的成像、更快的扫描速度和更复杂的资料分析工具等改进也使微阵列扫描器更加高效且用户友好。将自动化和软体解决方案整合到这些扫描器中以减少人工干预并提高吞吐量也将推动市场成长。

整个产业分为产品类型、应用、最终用途和地区。

根据产品类型，电荷耦合元件微阵列扫描仪领域的市场规模将因其高灵敏度和卓越的影像品质而在 2024 年至 2032 年期间获得显着成长。电荷耦合元件 (CCD) 技术能够以优异的分辨率精确侦测萤光讯号，这对于准确分析微阵列资料的复杂细节至关重要。基于 CCD 的扫描仪能够快速捕捉高解析度影像，这也提高了通量和效率，使其对于大规模基因组研究特别有价值。

在应用方面，由于候选药物高通量筛选和分析技术的快速采用，到 2032 年，药物发现领域的微阵列扫描仪产业将显着成长。微阵列扫描仪使研究人员能够同时评估数千个遗传和蛋白质靶点，以促进潜在药物化合物及其对各种生物途径的影响的识别。

由于强大的研究基础设施以及对基因组学和个人化医疗的投资不断增加，预计亚太地区微阵列扫描仪市场将在 2024 年至 2032 年期间产生可观的收入。慢性病盛行率的上升以及对客製化医疗保健解决方案的日益重视，进一步推动了对高通量技术的需求，促进了区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 基因组学和蛋白质组学研究的进展
  - 慢性病盛行率上升
  - 科技不断进步
- 产业陷阱与挑战
  - 与微阵列扫描器相关的高成本
  - 严格的监管要求
成长潜力分析
技术景观
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

主要趋势
萤光微阵列扫描仪
电荷耦合元件微阵列扫描仪
比色微阵列扫描仪
其他类型

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
基因表现分析
蛋白质微阵列
药物发现
基因分型和 SNP 分析
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院和诊所
製药和生物技术公司
诊断实验室
学术及研究机构
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Agilent Technologies, Inc.
Arrayit Corporation
Aushon BioSystems
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hitachi High-Tech Corporation
Illumina, Inc.
LI-COR Biosciences
Microarrays, Inc.
Oxford Gene Technology
PerkinElmer, Inc.
SciGene Corporation
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.

简介目录

Product Code: 9677

Microarray scanners market size will record 8.2% CAGR between 2024 and 2032 driven by the expanding applications of microarray technology in genomic research, personalized medicine, and diagnostics. Microarray scanners are essential for analyzing gene expression, genetic variations, and biomarkers across various research fields, including cancer research, drug discovery, and genetic disorder studies.

With researchers and clinicians seeking more detailed insights into genetic data to tailor treatments and develop new therapeutic approaches, the demand for advanced microarray scanners capable of delivering accurate and comprehensive results is on the rise. For instance, in August 2023, Thermo Fisher Scientific launched a new chromosomal microarray for increasing productivity, efficacy, and profitability in cytogenetic research labs.

Improvements, such as higher resolution imaging, increased scanning speed, and more sophisticated data analysis tools are also making microarray scanners more efficient and user-friendly. The integration of automation and software solutions into these scanners for reducing manual intervention and increasing throughput will also drive the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the market size from the charge-coupled devices microarray scanners segment will gain notable traction during 2024-2032 due to their high sensitivity and superior image quality. Charge-coupled device (CCD) technology enables precise detection of fluorescent signals with excellent resolution, which is crucial for accurately analyzing the intricate details of microarray data. The ability of CCD-based scanners to capture high-resolution images at a rapid pace is also enhancing throughput and efficiency, making them particularly valuable for large-scale genomic studies.

In terms of application, the microarray scanners industry from the drug discovery segment will witness significant growth up to 2032 driven by rapid adoption of technologies in high-throughput screening and analysis of drug candidates. Microarray scanners enable researchers to simultaneously evaluate thousands of genetic and protein targets for facilitating the identification of potential drug compounds and their effects on various biological pathways.

Asia Pacific microarray scanners market is expected to generate notable revenue during 2024-2032 attributed to the strong research infrastructure and increasing investments in genomics and personalized medicine. The rising prevalence of chronic diseases and the growing emphasis on tailored healthcare solutions are further propelling the demand for high-throughput technologies, adding to the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Advancements in genomics and proteomics research
  - 3.2.1.2 Rising prevalence of chronic diseases
  - 3.2.1.3 Growing technological advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with microarray scanners
  - 3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Fluorescence microarray scanners
5.3 Charge-coupled devices microarray scanners
5.4 Colorimetric microarray scanners
5.5 Other types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Gene expression analysis
6.3 Protein microarrays
6.4 Drug discovery
6.5 Genotyping and SNP analysis
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Pharmaceutical and biotechnology companies
7.4 Diagnostic laboratories
7.5 Academic and research institutes
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa